Electrocardiographic safety of repeated monthly dihydroartemisinin-piperaquine as a candidate for mass drug administration

Electrocardiographic safety of repeated monthly dihydroartemisinin-piperaquine as a candidate for mass drug administration

BACKGROUND: Mass drug administration (MDA) of sequential rounds of antimalarial drugs is being considered as a tool for malaria elimination. As an effective and long-acting antimalarial, Dihydroartemisinin-piperaquine (DHA/PQP) appears suitable as a candidate for MDA. However, absence of cardiac saf...

Full description

Bibliographic Details
Main Authors: Millat-Martínez, P., Ila, R., Laman, M., Robinson, L., Karunajeewa, H., Abel, H., Pulai, K., Sanz, S., Manning, L., Moore, Brioni, Bassat, Q., Mitjà, O.
Format: Journal Article
Published: American Society for Microbiology 2018
Online Access:http://hdl.handle.net/20.500.11937/73373

Similar Items

Similar Items